16.43
Precedente Chiudi:
$15.26
Aprire:
$15.73
Volume 24 ore:
2.10M
Relative Volume:
1.59
Capitalizzazione di mercato:
$1.12B
Reddito:
$2.73B
Utile/perdita netta:
$-1.13B
Rapporto P/E:
-0.9861
EPS:
-16.6622
Flusso di cassa netto:
$-83.00M
1 W Prestazione:
+1.61%
1M Prestazione:
-27.75%
6M Prestazione:
-44.21%
1 anno Prestazione:
-53.02%
Quidelortho Corporation Stock (QDEL) Company Profile
Nome
Quidelortho Corporation
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
QDEL
Quidelortho Corporation
|
16.43 | 1.04B | 2.73B | -1.13B | -83.00M | -16.66 |
|
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-09-19 | Ripresa | UBS | Neutral |
| 2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2024-03-04 | Downgrade | UBS | Neutral → Sell |
| 2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
| 2022-09-19 | Iniziato | Citigroup | Neutral |
| 2022-07-20 | Iniziato | UBS | Sell |
| 2022-06-17 | Ripresa | JP Morgan | Neutral |
| 2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Ripresa | Raymond James | Strong Buy |
| 2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Reiterato | Barclays | Overweight |
| 2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
| 2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Reiterato | Canaccord Genuity | Hold |
| 2017-02-17 | Iniziato | CL King | Neutral |
| 2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Reiterato | Barclays | Overweight |
| 2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Iniziato | Barclays | Overweight |
| 2013-07-31 | Reiterato | Canaccord Genuity | Buy |
| 2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corporation Borsa (QDEL) Ultime notizie
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45 - Markets Mojo
How does QuidelOrtho Corporation compare to its peers2026 Drop Watch & Fast Entry Momentum Alerts - baoquankhu1.vn
Value Recap: Does QuidelOrtho Corporation offer margin of safetyMarket Growth Report & Verified Stock Trade Ideas - baoquankhu1.vn
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08 - Markets Mojo
Precision Trading with Quidelortho Corp Com (QDEL) Risk Zones - Stock Traders Daily
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell shares are falling, what you need to know - MSN
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - TradingView
Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowHere's What Happened - MarketBeat
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Medtech business QuidelOrtho hires STAAR Surgical legal head as CLO - The Global Legal Post
QuidelOrtho names Nathaniel Sisitsky as chief legal officer By Investing.com - Investing.com Australia
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer - Sahm
QuidelOrtho (QDEL) Welcomes New Chief Legal Officer - GuruFocus
QuidelOrtho Announces Chief Legal Officer Leadership Transition - TipRanks
In Vitro Diagnostics Firm QuidelOrtho Picks New Legal Chief - Bloomberg Law News
QuidelOrtho Corporation Announces Chief Legal Officer Changes - marketscreener.com
QuidelOrtho names Nathaniel Sisitsky as chief legal officer - Investing.com
QuidelOrtho Corp. Hits Day Low of $16.16 Amid Price Pressure - Markets Mojo
QDEL SEC FilingsQuidel 10-K, 10-Q, 8-K Forms - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Stock Price Up 9.5%What's Next? - MarketBeat
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $15.08 - Markets Mojo
QuidelOrtho (QDEL) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
QuidelOrtho (QDEL) Morgan Stanley’s 22nd Annual Global Healthcare Conference summary - Quartr
QuidelOrtho (QDEL) Baird 2024 Global Healthcare Conference Summary - Quartr
Risk Report: Is QuidelOrtho Corporation stock technically oversold2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn
QuidelOrtho Corp stock hits new 52-week low amid persistent financial struggles and biotech sector h - AD HOC NEWS
QuidelOrtho Corp. Hits New 52-Week Low at $16.16 Amid Ongoing Struggles - Markets Mojo
QuidelOrtho Corp. Hits Day High with Strong 8.33% Intraday Surge - Markets Mojo
QuidelOrtho (NASDAQ:QDEL) Sets New 12-Month LowTime to Sell? - MarketBeat
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $17.03 - Markets Mojo
QuidelOrtho Corp. Hits Day Low at $17.03 Amid Price Pressure - Markets Mojo
RBC Capital Raises PT on QuidelOrtho Corporation From $60 to $62, Keeps Buy Rating - MSN
QuidelOrtho (NASDAQ:QDEL) Trading Down 8.3%Should You Sell? - MarketBeat
QuidelOrtho Plunges 9.6%: A Bearish Flash in the Healthcare Sector - Bitget
QuidelOrtho (NASDAQ:QDEL) Trading 9.3% HigherHere's What Happened - MarketBeat
EPS Watch: Is QuidelOrtho Corporation a turnaround story2026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
QuidelOrtho Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
QuidelOrtho Corp Stock (ISIN: US7476011036) Faces Institutional Shifts Amid Diagnostics Recovery Sig - AD HOC NEWS
QuidelOrtho Corporation $QDEL Shares Acquired by Aristotle Capital Boston LLC - MarketBeat
ArrowMark Colorado Holdings LLC Sells 181,325 Shares of QuidelOrtho Corporation $QDEL - MarketBeat
Why Is QuidelOrtho (QDEL) Down 24.5% Since Last Earnings Report? - Yahoo Finance
QuidelOrtho (QDEL) Valuation Check After Prolonged Share Price Weakness And Earnings Challenges - Yahoo Finance
QuidelOrtho Corp. Hits New 52-Week Low at $18.94 Amid Ongoing Struggles - Markets Mojo
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $19.24 - Markets Mojo
QuidelOrtho Corp. Forms Death Cross, Signaling Potential Bearish Trend - Markets Mojo
Chipmakers Recap: Will QuidelOrtho Corporation benefit from AI trends2026 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn
Stock Recap: Is QuidelOrtho Corporation a defensive stock2026 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Presents at 47th Annual Raymond James Institutional Investor ConferenceSlideshow (NASDAQ:QDEL) 2026-03-09 - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Hits New 1-Year LowHere's Why - MarketBeat
Quidelortho Corporation Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Quidelortho Corporation Azioni (QDEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):